Nurix Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2020 to Q1 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Nurix Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q1 2024.
  • Nurix Therapeutics, Inc. Operating Margin for the quarter ending February 29, 2024 was -195 %, a 55.9% increase year-over-year.
  • Nurix Therapeutics, Inc. annual Operating Margin for 2023 was -201 %, a 57.7% increase from 2022.
  • Nurix Therapeutics, Inc. annual Operating Margin for 2022 was -476 %, a 20.1% decline from 2021.
  • Nurix Therapeutics, Inc. annual Operating Margin for 2021 was -396 %, a 8.66% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -195 +247 +55.9% Dec 1, 2023 Feb 29, 2024
Q4 2023 -201 +275 +57.7% Sep 1, 2023 Nov 30, 2023
Q3 2023 -231 +210 +47.7% Jun 1, 2023 Aug 31, 2023
Q2 2023 -271 +131 +32.5% Mar 1, 2023 May 31, 2023
Q1 2023 -442 -45.4 -11.5% Dec 1, 2022 Feb 28, 2023
Q4 2022 -476 -79.8 -20.1% Sep 1, 2022 Nov 30, 2022
Q3 2022 -441 -97.1 -28.2% Jun 1, 2022 Aug 31, 2022
Q2 2022 -402 -7.54 -1.91% Mar 1, 2022 May 31, 2022
Q1 2022 -396 -10.7 -2.78% Dec 1, 2021 Feb 28, 2022
Q4 2021 -396 -31.6 -8.66% Sep 1, 2021 Nov 30, 2021
Q3 2021 -344 Jun 1, 2021 Aug 31, 2021
Q2 2021 -394 Mar 1, 2021 May 31, 2021
Q1 2021 -385 Dec 1, 2020 Feb 28, 2021
Q4 2020 -365 Sep 1, 2020 Nov 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.